Yourgene Health Share Discussion Threads

[scotty1] 18/10/2019 18:30

indeed doh twix 😒

[twix386] 18/10/2019 15:50

Doh Scotty! lol

[dj trading] 18/10/2019 14:46

Rathean - Yes
See

[rathean] 18/10/2019 12:09

Is it me or is the cash in hand looking like another raise might be required next year? 4.1 million but still cash burning at an impressive rate including product development for UK and Europe requirements, have I got my numbers wrong?

[scotty1] 17/10/2019 08:57

Online limits creeping up could see a little tick up today,the latest RNS should be filtering through now so may get a steady sustainable rise over the coming weeks.

[twix386] 16/10/2019 11:56

Yes thanks Scotty. Fwiw I'm sure both had the same views, so until TW left after finding his morals their advice was shared wisdom. Makes little difference.

[scotty1] 16/10/2019 07:41

twix TW no longer does the updates on YGEN he sold if you remember on ethical grounds,it's Steve Moore who still holds and does the updates.

[twix386] 16/10/2019 06:09

Is TW's latest of many " more (news) to come" likely to repeat all the other like minded claims...more news not meeting expectations and a falling sp! I really hope we appear to have turned the corner now and and TW's stopped clock will finally show the right time!

[dj trading] 15/10/2019 13:36

Cashburn calc from TS

YE cash £1.25m
Fundraise £11.3m? (£11.83 - £0.53 costs?)
Acquisition -£6.3m
1H TS Cash £4.1m

Burn £2.15m/6month (£4m/annum?)
(Further fundraising? this time next year or earlier if seeking further acquisition?)
imo dyor

Summary of important numbers
YE...Rev Cashburn
2016 2.5 8.2
2017 3.1 7.9
2018 6.1 10.2 (inc Yourgene)
2019 8.9 4.6
1H20 7.8 2.1 (6m and inc Elucigene)
dyor

[twix386] 15/10/2019 13:25

Hope so scotty, with weak share price reaction again. Been waiting through repeated price target and re-rate calls!

[scotty1] 15/10/2019 13:02

Yourgene Health – half-year trading update boosts shares… looks much more to come
By HotStockRockets | Tuesday 15 October 2019

[scotty1] 14/10/2019 22:46

From Bakky over the road

RE: RNS Today 15:54
I have asked the question with Walbrook and they confirm Illumina is expected 'early ' next year with rollout across Europe during the year. So no slippage it seems

[jestercat2] 14/10/2019 13:52

Indeed Scrutable, I'm topping up at these levels now and excited by what's now unfolding. Genuinely excellent story here now.

[scrutable] 14/10/2019 12:45

Shareholders must pinch themselves to become aware that most of the company's increasing problems were cured last year. Very healthy growth continues (34% - £1,2m more sales) in its original NIPT business, but much more has been added(£1.6m) from reproductive and Health sectors. The FY report in July heralded first results from the USA later this year.. India and France were gaining traction I look forward to more start up figures from Japan, Brazil and Egypt - all with large population increases

The high growth rate is actually accelerating with so much more time available to management after coming to terms with Illumina. They can at last concentrate fully on the basic potential of the business, which now looks very undervalued.

This is one of the most striking recovery situations available to investors, substsntantially derisked, and quite exciting to follow. A litte more newsflow would be justified and appreciated.

[scotty1] 14/10/2019 11:50

Agree jester can see the share price starting to rise steadily as news filters through.

[jestercat2] 14/10/2019 11:46

Very happy with those figures. share price should respond positively, but sometimes takes a day or two for the news to trickle through.

[mhw28865] 14/10/2019 11:38

Im v surprised by the muted response to some very good half year figures today. Are we ever going to break 20p again!

[scotty1] 14/10/2019 08:35

Agreed ngen we will be more than fine and now have a good solid diversified business building up nicely going forwards.

[ngen yap] 14/10/2019 08:11

Smithless, they had 1m at year end. Cash spent on R&D primarily, and we should be ebitda positive already I reckon. So we are fine.

[toyin] 14/10/2019 08:09

-- Net cash (cash less borrowings) at year-end of GBP1.0m (2018: GBP11.9m net debt), prior to post period-end fundraise and associated acquisition of Elucigene Diagnostics ("Elucigene")

Had £1m at Y/E
Raised £11m net (being kind)
Cash of £12m
Purchase £6.3m (not cashburn)
Cash left £5.7m
Cash today £4.1m

So burn between march & sept = £1.6m

[twix386] 14/10/2019 08:08

Do you not think assuming no more acquisitions that increasing revenue will plug the gap?

[smithless] 14/10/2019 08:01

had £4m yend raised £11m april (say £10m after fees), today states has £4m as of Sept, thus £10m spent. £6m on Elucigene, so £4m loss H1. So yes will have to increase top line AMBITIOUSLY as scotty states, otherwise back for more cash

[toyin] 14/10/2019 07:47

smithless, please tell how they have done £10m+ cash burn?

[ngen yap] 14/10/2019 07:35

Very strong results. 56% organic growth excluding acquisition! We could reach 18m for FY, as per my forecast and ahead of broker's forecast! Wonderful.